Featured
European Biotech Week 2021
The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech […]
Free
Loading view.
Healthcare Biotech
EU4Health 2021 Work Programme | Info Session on HERA Procurement Calls
The European Health and Digital Executive Agency (HaDEA) with the support of the European Commission organizes an info session to present three HERA’s public procurement calls […]
Featured
Rare Conversations Conference | European Rare Disease Ecosystem: A Collaborative Path Forward
Join the inaugural Rare Conversations Conference aimed at facilitating essential discussion on the future of the rare disease and OMP ecosystem involving leading experts.The event will […]
Featured
EuropaBio 25th Anniversary | mRNA: A voyage of discovery and celebration
The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool.
Featured
Introducing the Innovative Health Initiative: Europe’s new partnership for health
The Innovative Health Initiative (IHI) aims to build on the successes of the Innovative Medicines ...
Rare Conversations 2022!
Managing uncertainties in rare disease innovation Joins us for the new episode of Rare Conversations 2022! The second episode of Rare Conversations 2022 will build on […]
Featured
European Biotech Week 2022: At the cutting edge of biotechnology for cardiovascular diseases: A World Heart Day special edition webinar
Healthcare Biotechnology has the potential to transform how healthcare is delivered to patients, both in terms of innovative treatments, but also via use of innovative prevention, […]
Featured
EuropaBio Patient BioForum 2022: Toward a Common Understanding of Unmet Medical Needs
EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations and the biopharmaceutical industry. […]
Featured
SME BioForum: Rare diseases
Rare Disease Day takes place on February 28th across the globe to raise awareness among policymakers and the public about rare diseases and their impact on patient's lives and their families...
Featured
Development of Orphan Biologics: Challenges and Opportunities
CatalentThe development of therapies (OMPs) for rare diseases comes with distinct challenges, including patient recruitment, setting meaningful clinical endpoints, manufacturing and supply and finding the regulatory and market pathway to ensure patients can access therapy.
EU Healthcare and Pharmaceutical Policy in 2023: What You Need to Know
From the ongoing revision of the EU pharmaceutical legislation package and addressing critical supply issues to the impact of the recent Medical Device Regulation transition period extension, the challenges in EU healthcare and pharmaceutical policy are ever-evolving.
SMEs in a Changing World: The Impact of the Revision of the Pharmaceutical Legislation on Europe’s innovative SMEs
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem.